SlideShare a Scribd company logo
1 of 13
 
About PharmMD ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Technology Results ,[object Object],[object Object],[object Object],[object Object],[object Object],People ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Methods ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PharmMD “Apps” Health and Human Capital Management PMD Platform State-of-the Art Cloud Environment ROI & Reporting Data Analytics Engine Data Collection
The Problem:  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],The   Solution :  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Standardized Processes - The PharmMD Way A standardized process that builds patient understanding of the need to receive MTM services. With the PharmMD way, people understand “What’s in it for THEM!”
The PharmMD CPL ® The CPL ™  allows clinicians to code clinical rules using multiple variables, including ICD-9 codes, without needing a computer programmer! This enables a highly customized and responsive program to deliver results. Once developed, the rule can be tested to identify how many patients are identified within the rule criteria. Once satisfied the rule is activated and the drug therapy problems are automatically created in the system! condition("Asthma") or icd9("493.00","493.01","493.02","493.10","493.11","493.12","493.20","493.21","493.22","493.81","493.82","493.90","493.92")
DTP Score Clinical Rules Generate Drug Therapy Problems with severity scoring (DTP Score™) to enable clinicians to focus on what is important.  DTP Scoring can include a time-based factor or be strictly focused on severity.
Result Check™ In this example, the MedPro 2.0 system looks to see that the inappropriate medication is not dispensed. Finding that it is not, the DTP status is changed to  “Closed: Resolved”  and is fully reportable as a successful intervention.
Result Check™ Results can then be reported in summary, disease-specific, DTP category, and population categories to show effectiveness and determine how to target desired groups
PharmMD National Pharmacist Network
Drug Therapy Problem Summary by category
Client Results * Note: client results will vary based upon several factors including formulary design, current client population’s health, MTM services implemented ,[object Object],[object Object],[object Object],[object Object],Rx   Medical   Total   Intervention Population PMPM Intervention PMPM Intervention PMPM Baseline Period PMPM $  252.74  Baseline Period PMPM $  610.38  Baseline Period PMPM $  863.12  Intervention Period PMPM $  237.16  Intervention Period PMPM $  538.53  Intervention Period PMPM $  775.69  Unadjusted Trend  -6.16% Unadjusted Trend  -11.77% Unadjusted Trend  -10.13% NonIntervention Trend (see below) -3.19% NonIntervention Trend (see below) 9.38% NonIntervention Trend (see below) 6.60% Expected NonIntervention PMPM $  244.68  Expected NonIntervention PMPM $  667.63  Expected NonIntervention PMPM $  920.05  Savings (Increase) $  7.52  Savings (Increase) $  129.10  Savings (Increase) $  144.36  NonIntervention Population PMPM NonIntervention PMPM NonIntervention PMPM Baseline Period PMPM $  105.07  Baseline Period PMPM $  369.25  Baseline Period PMPM $  474.32  Intervention Period PMPM $  101.72  Intervention Period PMPM $  403.89  Intervention Period PMPM $  505.61  NonIntervention Trend -3.19% NonIntervention Trend 9.38% NonIntervention Trend 6.60%
Medication Action Plan to Prescriber  MAP – with target response

More Related Content

What's hot

Alcohol and Drugs in the Workplace
Alcohol and Drugs in the Workplace Alcohol and Drugs in the Workplace
Alcohol and Drugs in the Workplace Andrew Schwartz
 
Politico Pro Health Care Briefing: Drug Safety and the Trump FDA
Politico Pro Health Care Briefing: Drug Safety and the Trump FDAPolitico Pro Health Care Briefing: Drug Safety and the Trump FDA
Politico Pro Health Care Briefing: Drug Safety and the Trump FDACVS Health
 
TITAN Frequently Asked Questions
TITAN Frequently Asked QuestionsTITAN Frequently Asked Questions
TITAN Frequently Asked QuestionsTheTitanGroupLLC
 
472_Strategies to Reduce Medication Errors
472_Strategies to Reduce Medication Errors472_Strategies to Reduce Medication Errors
472_Strategies to Reduce Medication Errorssuneela amjad
 
The E-prescribing Informational
The E-prescribing InformationalThe E-prescribing Informational
The E-prescribing InformationalDrFirst
 
Pharmacy Technician Information Booklet
Pharmacy Technician Information BookletPharmacy Technician Information Booklet
Pharmacy Technician Information BookletTam Nguyen
 
What is e prescribing
What is e prescribingWhat is e prescribing
What is e prescribingMyez Pharmacy
 

What's hot (13)

Alcohol and Drugs in the Workplace
Alcohol and Drugs in the Workplace Alcohol and Drugs in the Workplace
Alcohol and Drugs in the Workplace
 
Third party Financial Issues
Third party Financial IssuesThird party Financial Issues
Third party Financial Issues
 
Brochure
BrochureBrochure
Brochure
 
Employee Drug Testing
Employee Drug TestingEmployee Drug Testing
Employee Drug Testing
 
Politico Pro Health Care Briefing: Drug Safety and the Trump FDA
Politico Pro Health Care Briefing: Drug Safety and the Trump FDAPolitico Pro Health Care Briefing: Drug Safety and the Trump FDA
Politico Pro Health Care Briefing: Drug Safety and the Trump FDA
 
CPOE
CPOECPOE
CPOE
 
TITAN Frequently Asked Questions
TITAN Frequently Asked QuestionsTITAN Frequently Asked Questions
TITAN Frequently Asked Questions
 
472_Strategies to Reduce Medication Errors
472_Strategies to Reduce Medication Errors472_Strategies to Reduce Medication Errors
472_Strategies to Reduce Medication Errors
 
Importance of a medicare review
Importance of a medicare reviewImportance of a medicare review
Importance of a medicare review
 
Cancer test kit
Cancer test kitCancer test kit
Cancer test kit
 
The E-prescribing Informational
The E-prescribing InformationalThe E-prescribing Informational
The E-prescribing Informational
 
Pharmacy Technician Information Booklet
Pharmacy Technician Information BookletPharmacy Technician Information Booklet
Pharmacy Technician Information Booklet
 
What is e prescribing
What is e prescribingWhat is e prescribing
What is e prescribing
 

Similar to PharmMD

Rx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hannaRx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hannaOPUNITE
 
Us Health System Ppt
Us Health System PptUs Health System Ppt
Us Health System Pptasadhu86
 
Fronzi (Ghc)
Fronzi (Ghc)Fronzi (Ghc)
Fronzi (Ghc)TORC
 
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?Canadian Organization for Rare Disorders
 
2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond AndersonStarttech Ventures
 
WP_Life Sciences_Drug Utilization_Alok Anand
WP_Life Sciences_Drug Utilization_Alok AnandWP_Life Sciences_Drug Utilization_Alok Anand
WP_Life Sciences_Drug Utilization_Alok AnandAlok Anand
 
Physician dispensing services doctor dispensing brp pharmaceuticals
Physician dispensing services  doctor dispensing   brp pharmaceuticalsPhysician dispensing services  doctor dispensing   brp pharmaceuticals
Physician dispensing services doctor dispensing brp pharmaceuticalsPhysician Dispensing
 
Himss 10 Myths Of Pharmacy interoperability
Himss 10 Myths Of Pharmacy interoperabilityHimss 10 Myths Of Pharmacy interoperability
Himss 10 Myths Of Pharmacy interoperabilitypoikonen
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxodiliagilby
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxavaforman16457
 
Prescription Audit PPT.pptx
Prescription Audit PPT.pptxPrescription Audit PPT.pptx
Prescription Audit PPT.pptxkoushikMazumder6
 
Pdmp 2 small kim_lev_zarate
Pdmp 2 small kim_lev_zaratePdmp 2 small kim_lev_zarate
Pdmp 2 small kim_lev_zarateOPUNITE
 
Rx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerRx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerOPUNITE
 
Driving innovation procurement forward International Perspective: What can we...
Driving innovation procurement forward International Perspective: What can we...Driving innovation procurement forward International Perspective: What can we...
Driving innovation procurement forward International Perspective: What can we...Consorci de Salut i Social de Catalunya
 
06 Am09 Presentations Gutman
06 Am09 Presentations   Gutman06 Am09 Presentations   Gutman
06 Am09 Presentations GutmanSimon Prince
 
Drug Utilization in a regulated Enviorment
Drug Utilization in a regulated EnviormentDrug Utilization in a regulated Enviorment
Drug Utilization in a regulated EnviormentAlok Anand
 

Similar to PharmMD (20)

Rx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hannaRx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hanna
 
Us Health System Ppt
Us Health System PptUs Health System Ppt
Us Health System Ppt
 
Fronzi (Ghc)
Fronzi (Ghc)Fronzi (Ghc)
Fronzi (Ghc)
 
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
 
Systems to Support Medicines Reconciliation at TDHB
Systems to Support Medicines Reconciliation at TDHBSystems to Support Medicines Reconciliation at TDHB
Systems to Support Medicines Reconciliation at TDHB
 
2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson
 
WP_Life Sciences_Drug Utilization_Alok Anand
WP_Life Sciences_Drug Utilization_Alok AnandWP_Life Sciences_Drug Utilization_Alok Anand
WP_Life Sciences_Drug Utilization_Alok Anand
 
Physician dispensing services doctor dispensing brp pharmaceuticals
Physician dispensing services  doctor dispensing   brp pharmaceuticalsPhysician dispensing services  doctor dispensing   brp pharmaceuticals
Physician dispensing services doctor dispensing brp pharmaceuticals
 
Informatics Primer
Informatics PrimerInformatics Primer
Informatics Primer
 
Himss 10 Myths Of Pharmacy interoperability
Himss 10 Myths Of Pharmacy interoperabilityHimss 10 Myths Of Pharmacy interoperability
Himss 10 Myths Of Pharmacy interoperability
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docx
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docx
 
Prescription Audit PPT.pptx
Prescription Audit PPT.pptxPrescription Audit PPT.pptx
Prescription Audit PPT.pptx
 
Pdmp 2 small kim_lev_zarate
Pdmp 2 small kim_lev_zaratePdmp 2 small kim_lev_zarate
Pdmp 2 small kim_lev_zarate
 
China
ChinaChina
China
 
Rx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerRx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinner
 
Driving innovation procurement forward International Perspective: What can we...
Driving innovation procurement forward International Perspective: What can we...Driving innovation procurement forward International Perspective: What can we...
Driving innovation procurement forward International Perspective: What can we...
 
Twillman preventing rx abuse
Twillman preventing rx abuseTwillman preventing rx abuse
Twillman preventing rx abuse
 
06 Am09 Presentations Gutman
06 Am09 Presentations   Gutman06 Am09 Presentations   Gutman
06 Am09 Presentations Gutman
 
Drug Utilization in a regulated Enviorment
Drug Utilization in a regulated EnviormentDrug Utilization in a regulated Enviorment
Drug Utilization in a regulated Enviorment
 

PharmMD

  • 1.  
  • 2.
  • 3. PharmMD “Apps” Health and Human Capital Management PMD Platform State-of-the Art Cloud Environment ROI & Reporting Data Analytics Engine Data Collection
  • 4.
  • 5. Standardized Processes - The PharmMD Way A standardized process that builds patient understanding of the need to receive MTM services. With the PharmMD way, people understand “What’s in it for THEM!”
  • 6. The PharmMD CPL ® The CPL ™ allows clinicians to code clinical rules using multiple variables, including ICD-9 codes, without needing a computer programmer! This enables a highly customized and responsive program to deliver results. Once developed, the rule can be tested to identify how many patients are identified within the rule criteria. Once satisfied the rule is activated and the drug therapy problems are automatically created in the system! condition("Asthma") or icd9("493.00","493.01","493.02","493.10","493.11","493.12","493.20","493.21","493.22","493.81","493.82","493.90","493.92")
  • 7. DTP Score Clinical Rules Generate Drug Therapy Problems with severity scoring (DTP Score™) to enable clinicians to focus on what is important. DTP Scoring can include a time-based factor or be strictly focused on severity.
  • 8. Result Check™ In this example, the MedPro 2.0 system looks to see that the inappropriate medication is not dispensed. Finding that it is not, the DTP status is changed to “Closed: Resolved” and is fully reportable as a successful intervention.
  • 9. Result Check™ Results can then be reported in summary, disease-specific, DTP category, and population categories to show effectiveness and determine how to target desired groups
  • 11. Drug Therapy Problem Summary by category
  • 12.
  • 13. Medication Action Plan to Prescriber MAP – with target response